Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease

被引:84
作者
Garcia-Olmo, Damian [1 ]
Garcia-Arranz, Mariano [1 ]
Herreros, Dolores [1 ]
机构
[1] Univ Autonoma Madrid, Serv Cirugia Gen, Hosp Univ La Paz, Dept Surg & Cell Therapy, Madrid 28046, Spain
关键词
adipose derived stem cells; cell therapy; Crohn's disease; mesenchymal stem cells; perianal fistula; stem cells;
D O I
10.1517/14712598.8.9.1417
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Complex perianal fistulising disease is a distressing condition. In patients without Crohn's disease, surgery is the mainstay treatment but faecal incontinence and recurrence are high. Infliximab is used in Crohn's patients but not all respond to therapy. Objective: After an evaluation of the current treatment options, we discuss studies of adipose-derived stem cell (ASC) therapy, a novel approach for treating complex perianal fistulas. Methods: ASCs are obtained from a liposuction procedure and a subsequent expansion process. They are administered according to a strict protocol which involves infusion of the cells into the target lesion along with fibrin glue. Results/conclusions: A Phase IIb study comparing ASC and fibrin glue therapy with fibrin glue therapy alone showed that ASCs were effective at inducing healing in complex perianal fistulas.
引用
收藏
页码:1417 / 1423
页数:7
相关论文
共 40 条
[1]   In vitro differentiation of human processed lipoaspirate cells into early neural progenitors [J].
Ashjian, PH ;
Elbarbary, AS ;
Edmonds, B ;
DeUgarte, D ;
Zhu, M ;
Zuk, PA ;
Lorenz, HP ;
Benhaim, P ;
Hedrick, MH .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (06) :1922-1931
[2]  
BERNSTEIN LH, 1980, GASTROENTEROLOGY, V79, P599
[3]  
BRANDT LJ, 1982, GASTROENTEROLOGY, V83, P383
[4]   Epithelial differentiation of human adipose tissue-derived adult stem cells [J].
Brzoska, M ;
Geiger, H ;
Gauer, S ;
Baer, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 330 (01) :142-150
[5]   European evidence based consensus on the diagnosis and management of Crohn's disease: special situations [J].
Caprilli, R ;
Gassull, MA ;
Escher, JC ;
Moser, G ;
Munkholm, P ;
Forbes, A ;
Hommes, DW ;
Lochs, H ;
Angelucci, E ;
Cocco, A ;
Vucelic, B ;
Hildebrand, H ;
Kolacek, S ;
Riis, L ;
Lukas, M ;
de Franchis, R ;
Hamilton, M ;
Jantschek, G ;
Michetti, P ;
O'Morain, C ;
Anwar, MM ;
Freitas, JL ;
Mouzas, IA ;
Baert, F ;
Mitchel, R ;
Hawkey, CJ .
GUT, 2006, 55 :i36-i58
[6]   Future of fat as raw material for tissue regeneration [J].
De Ugarte, DA ;
Ashjian, PH ;
Elbarbary, A ;
Hedrick, MH .
ANNALS OF PLASTIC SURGERY, 2003, 50 (02) :215-219
[7]   Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor [J].
Dieckgraefe, BK ;
Korzenik, JR .
LANCET, 2002, 360 (9344) :1478-1480
[8]   Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine [J].
Egan, LJ ;
Sandborn, WJ ;
Tremaine, WJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :442-448
[9]   Patient satisfaction after surgical treatment for fistula-in-ano [J].
García-Aguilar, J ;
Davey, CS ;
Le, CT ;
Lowry, AC ;
Rothenberger, DA .
DISEASES OF THE COLON & RECTUM, 2000, 43 (09) :1206-1212
[10]   A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation [J].
García-Olmo, D ;
García-Arranz, M ;
Herreros, D ;
Pascual, I ;
Peiro, C ;
Rodríguez-Montes, JA .
DISEASES OF THE COLON & RECTUM, 2005, 48 (07) :1416-1423